ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,949.91
      1.83%
      US Tech 100
      20,761.60
      0.45%
      Dow Jones
      43,221.55
      1.65%
      Brent Oil
      80.40
      -1.57%
      Bitcoin
      99,089.77
      -1.42%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Carmell Corporation (CTCX)

      7. Carmell Corporation (CTCX) News

      Carmell Corporation

      Carmell Corporation (CTCX)

      NASDAQ
      0.5315
      -0.08435
      (-13.70%)
      Closed January 15 4:00PM
      Delayed by 15 minutes
      0.5314
      -0.0001
      ( -0.02% )
      Pre Market: 6:14AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      CTCX News

      Official News Only

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 05 2024
      CTCX (-13.70%)

      CTCX Discussion

      View Posts
      glenn1919 glenn1919 2 weeks ago
      ctcx.......................weeeeeeeeeeeeeeeeeeeeeeeeee
      👍️0
      declaes declaes 2 weeks ago
      The volume in the past few days was telling  I hope you all got in 🤑
      👍️0
      Invest-in-America Invest-in-America 2 weeks ago
      CTCX: Bust that damn DOLLAR!!!
      👍️0
      Invest-in-America Invest-in-America 2 weeks ago
      CTCX: Kick that ASK!!!!!
      👍️0
      Invest-in-America Invest-in-America 2 weeks ago
      CTCX: My E-Turd gave me BIG problems, simply tryin' to grab this rocket ship today!! I DID get a decent price, but COULD have grabbed it like an insider at the PR firm just before they launched the NEWS!!! (I know, that's illegal --- but I wish I was only age 21 right now, & workin' at "GlobeNewswire" PR desk, for example!!! E.g., "Hello, MOM, grab a bunch of CTCX for us right now!!! I'm gonna tap the PR launch button in circa 10-minutes!!!")
      👍️0
      tw0122 tw0122 2 weeks ago
      Yes acquiring $ELAB $2.41 assets .72 +'156% 
      👍️0
      Invest-in-America Invest-in-America 2 weeks ago
      CTCX: Good news!!
      👍️0
      glenn1919 glenn1919 3 weeks ago
      CTCX...............https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
      👍️0
      tw0122 tw0122 3 weeks ago
      8 million shares priced at .23 for commercial launch 
      👍️0
      tw0122 tw0122 3 weeks ago
      1.8 private placemt and up it goes .47 + 110%
      👍️0
      glenn1919 glenn1919 1 month ago
      ctcx......https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 2 months ago
      CTCX, new 52 week low
      👍️0
      glenn1919 glenn1919 3 months ago
      CTCX..............................https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
      👍️0
      tw0122 tw0122 3 months ago
      .56 + 16% Run run another pump whoops might be too late lol
      👍️0
      Invest-in-America Invest-in-America 3 months ago
      CTCX: And STILL under $2.00.

      _____________________________________________________________________
      I'm producing a film, "American Cars of 1908" --- tap link below for latest edition:
      https://i.giphy.com/media/v1.Y2lkPTc5MGI3NjExOXVyb2N1NXVkejE5em04cDMyYnRvbDV2ejAzeHdsdmZzc2JxajQwZSZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/f1NTdkdbG4XzW/giphy.gif
      👍️0
      glenn1919 glenn1919 3 months ago
      CTCX...................................https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Awl416 Awl416 3 months ago
      Oh cmon
      👍️0
      frans frans 3 months ago
      CTCX 0.53 X 0.53
      👍️0
      tw0122 tw0122 3 months ago
      Ok .50 now
      👍️0
      Monksdream Monksdream 6 months ago
      CTCX under $2
      👍️0
      Monksdream Monksdream 6 months ago
      CTCX under $2
      👍️0
      stock1ace1 stock1ace1 1 year ago
      Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

      https://www.businesswire.com/news/home/20230809916251/en/Carmell-Announces-Successful-Closing-of-Merger-with-Axolotl-Biologix-and-Launch-of-a-New-Brand-Identity
      👍️0
      stock1ace1 stock1ace1 1 year ago
      CTCX $2.90 #merger complete rsi 22 oversold macd crossover bullish

      https://stockcharts.com/h-sc/ui?s=Ctcx
      👍️0
      AJ Freely AJ Freely 1 year ago
      $CTCX - Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
      Up 57% Pre-Market/ Current Price $4.74
      👍️0
      Monksdream Monksdream 1 year ago
      Carmell Therapeutics Corp NASDAQ: CTCX*

      GoSymbol lookup
      *Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
      Health Care : Biotechnology | Company profile
      Carmell Therapeutics Corporation is a regenerative medicine platform company. The Company is engaged in the development of allogeneic plasma-based bioactive material (PBM) that is designed to boost innate regenerative pathways across a variety of bone and soft tissue indications. The PBM technology is licensed from Carnegie Mellon University and claims the ability to plasticize whole plasma and cross link with genipin, a derivative of the gardenia plant, to provide a controlled degradation profile in vivo. The Company’s lead product, CT-101 Bone Healing Accelerant (BHA), a biologic, is designated by the United States Food and Drug Administration (FDA) as a combination product, containing the Company’s core technology of PBM plus B Tri-Calcium Phosphate (B-TCP) an already approved medical device. The Company has FDA clearance for a Phase II-stage clinical trial designed to study accelerated healing and reduced infections in open tibia (shinbone) fractures with intramedullary rodding.
      Carmell Therapeutics Corp NASDAQ: CTCX*

      GoSymbol lookup
      *Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
      Health Care : Biotechnology | Company profile
      Carmell Therapeutics Corporation is a regenerative medicine platform company. The Company is engaged in the development of allogeneic plasma-based bioactive material (PBM) that is designed to boost innate regenerative pathways across a variety of bone and soft tissue indications. The PBM technology is licensed from Carnegie Mellon University and claims the ability to plasticize whole plasma and cross link with genipin, a derivative of the gardenia plant, to provide a controlled degradation profile in vivo. The Company’s lead product, CT-101 Bone Healing Accelerant (BHA), a biologic, is designated by the United States Food and Drug Administration (FDA) as a combination product, containing the Company’s core technology of PBM plus B Tri-Calcium Phosphate (B-TCP) an already approved medical device. The Company has FDA clearance for a Phase II-stage clinical trial designed to study accelerated healing and reduced infections in open tibia (shinbone) fractures with intramedullary rodding.
      👍️0

      Your Recent History

      NASDAQ
      CTCX
      Carmell
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads